Peptide reconstitution water: does BAC water type actually matter?

What did @coachkatie.rogers actually say?

She noticed her AOD-9604 peptide had turned into a visible clump after reconstitution and was unsure whether she added bacteriostatic water too fast or received a defective bottle. She acknowledged that "this particular peptide is prone to this happening" and made the responsible call not to inject it. She reached out to her supplier for a replacement. No health claims were made about AOD-9604's effects, and she did not encourage anyone else to inject a clumped product.

To be clear, this video is less a claims-heavy wellness post and more a troubleshooting moment shared in public. That framing matters for how we evaluate it. She's not selling anything here. She's flagging a reconstitution problem she didn't fully understand, which is a useful data point for the community she's speaking to.

Does the science back this up?

Yes, broadly. AOD-9604 is a peptide fragment derived from the C-terminus of human growth hormone (hGH), and like most lyophilized peptides, it can aggregate or clump under specific conditions. The speed of solvent addition, temperature, and pH of the bacteriostatic water all matter.

Peptide aggregation is a documented formulation challenge. Proteins and peptides in lyophilized form are thermodynamically unstable and can misfold or aggregate when rehydrated improperly. Research in peptide pharmaceutical stability, including work by Carpenter et al. (1997, Pharmaceutical Research), has shown that reconstitution rate and solvent temperature directly affect aggregate formation in lyophilized biologics. Adding water too quickly can create localized concentration spikes that promote aggregation before the peptide fully dissolves.

AOD-9604 specifically has a relatively short amino acid sequence (15 residues), but its hydrophobic regions make it susceptible to self-association, particularly if the reconstitution environment is not optimal. Her instinct that she may have added the water too fast is scientifically plausible.

What did they get wrong (or right)?

She got the important part right: she did not inject it. That deserves credit. Injecting a visibly aggregated peptide is a real risk. Protein aggregates can act as immunogenic particles, triggering inflammatory or immune responses at the injection site. This is not theoretical. The FDA's guidance on injectable biologics specifically flags visible particulate matter as a disqualifying observation before use.

Where the video leaves a gap is in explaining why reconstitution technique matters. She says "I guess it's very particular on the type of B-A-C water you use" in her caption, but bacteriostatic water type is actually a secondary concern compared to technique. The pH of the water, the angle of injection into the vial, and the rate of addition matter more than brand. Framing it primarily as a water-type issue could send viewers chasing a product solution when the fix is usually procedural.

She also notes "I know this particular peptide is prone to this happening" without explaining why. That's accurate but incomplete, and for a 7,000-view audience that may be reconstituting peptides themselves, the missing explanation is a real gap.

What should you actually know?

If you are reconstituting any lyophilized peptide, technique is the variable most in your control. Tilt the vial at an angle, add bacteriostatic water slowly down the glass wall rather than directly onto the powder, and avoid agitating or shaking the vial. Let it dissolve by gentle swirling or refrigeration. Adding solvent too quickly is one of the most common causes of clumping across all peptide classes, not just AOD-9604.

On the product itself: AOD-9604 is not FDA-approved for any indication. It was studied in clinical trials for obesity (Heffernan et al., 2001, Obesity Research) but did not reach regulatory approval. It is currently sold as a research compound. Any telehealth platform dispensing it is operating in a regulatory gray area, and compounded versions have not been evaluated for bioequivalence to any approved standard. If you are using it under medical supervision, reconstitution guidance should come from that provider, not a TikTok comment section.

Visible clumping, cloudiness, or particulate matter in a reconstituted peptide is always a reason to stop and replace the vial. Her decision not to inject it was the right one.